Homeopathy for treatment of irritable bowel syndrome [entry]

Emily J Peckham, E Andrea Nelson, Joanne Greenhalgh, Katy Cooper, Elizabeth R Roberts, Anurag Agrawal, Emily J Peckham
2012 Cochrane Database of Systematic Reviews   unpublished
Data collection and analysis Two authors independently assessed the risk of bias and extracted data. The primary outcome was global improvement in IBS as measured by an IBS symptom severity score. Secondary outcomes included quality of life, abdominal pain, stool frequency, stool consistency, and adverse events. The overall certainty of the evidence supporting the primary and secondary outcomes was assessed using the GRADE criteria. We used the Cochrane risk of bias tool to assess risk of bias.
more » ... We calculated the mean difference (MD) and 95% confidence interval (CI) for continuous outcomes and the risk ratio (RR) and 95% CI for dichotomous outcomes. Main results Four RCTs (307 participants) were included. Two studies compared clinical homeopathy (homeopathic remedy, asafoetida or asafoetida plus nux vomica) to placebo for IBS with constipation (IBS-C). One study compared individualised homeopathic treatment (consultation plus remedy) to usual care for the treatment of IBS in female patients. One study was a three armed RCT comparing individualised home- Homeopathy for treatment of irritable bowel syndrome (Review) Summary of findings for the main comparison. Homeopathy versus placebo Homeopathy versus placebo for the treatment of irritable bowel syndrome Patient or population: patients with irritable bowel syndrome Settings: outpatients Intervention: homeopathy *The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CI: Confidence interval; RR: Risk ratio; GRADE Working Group grades of evidence High quality: Further research is very unlikely to change our confidence in the estimate of effect. Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. Cochrane Library Trusted evidence. Informed decisions. Better health.
doi:10.1002/14651858.cd009710 fatcat:vxxr2jp57zeqzf5zucxw67n7qu